Delivery Order SPE2DB24D2205-SPE2DB24FDYMN

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,404.98 firm-fixed-price contract is for the supply of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $12,525.32 and will run through September 10, 2024. It involves the delivery of the prescription medication RINVOQ ER 15 MG TABLET. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999, for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. for the supply of RINVOQ ER 15 MG TABLET. The order has a ceiling value of $7,594.49 and a completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Medical Supply Chain. The award is for the supply of RINVOQ ER 45 MG TABLET, a pharmaceutical product, with a ceiling value of $29,368.42 and a completion date of June 28, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET (a medication used to treat certain autoimmune conditions). The contract has a ceiling value of $83,142.15 and is a firm fixed-price delivery order with a performance period through May 7, 2025. The contract is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a pharmaceutical product, RINVOQ ER 15 MG TABLET, with a ceiling value of $8,796.95 and a period of performance through June 26, 2025. The contract is structured as a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a $50,563.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication used to treat various medical conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $25,709.50 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a prescription medication. The contract has a period of performance through September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,245.30, is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product. The contract has a ceiling value of $35,203.25 and an ultimate completion date of October 16, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for providing the requested medication...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDYMN
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET in 30-count units. The contract has a ceiling value of $10,341.35, is a Firm Fixed Price contract, and does not utilize any set-asides.

The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This specific delivery order is for the supply of the rheumatoid arthritis medication RINVOQ, with a performance period lasting until August 15, 2024.

AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award. As the company holds numerous federal contracts for pharmaceutical and medical supply provision, it leverages its extensive distribution network to deliver critical care materials to various government agencies, including the Department of Defense, Veterans Affairs, and other federal healthcare providers.

Generated 11/13/24, 9:08 AM